Organization · Venture Capital
Human Plus Fund
Human Plus Fund is an Amsterdam-based early-stage investment fund focused on translating innovative biomedical research into market-ready products and treatments. It aims to bridge the funding gap between public research and private investment in the biomedical sector.
Overview
What Human Plus Fund does
What Human Plus Fund is
Human Plus Fund is an Amsterdam-based early-stage investment fund focused on translating innovative biomedical research into market-ready products and treatments. It aims to bridge the funding gap between public research and private investment in the biomedical sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Human Plus Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
Human Plus Fund as a funder
Investment thesis
Human Plus invests where biomedical research has patient-benefit potential but is too early for many private commercial investors and not well served by public research funding alone. The fund's model combines co-financing, technical and translational feasibility assessment, project-selection risk mitigation, international expert support, and spin-off company formation.
Focus narrative
Human+ Fund focuses on supporting innovative product development in biomedical technology, diagnostics, and pharmaceutical products. The fund aims to bridge the gap between public and private funding in biomedical research, addressing the stagnation in the development of new biomedical products. It employs a unique co-financing model to foster high-potential research projects and aims to create impact for patients while generating a return on investment for funders.
Value beyond capital
Human Plus Fund provides translational capital and development expertise to biomedical researchers and entrepreneurs, facilitating the formation of spin-off companies and supporting innovative projects that have the potential for significant patient impact.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Sectors
- Biotech · Healthcare · Diagnostics
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Spatium Medical: A spin-off from Erasmus MC in Rotterdam, developing advanced insufflation technology. Bcon Medical: Designs electromagnetic navigation systems to improve cancer surgery. CRCbioscreen: Focuses on preventing death from colorectal cancer through early diagnostic tools that combine protein biomarkers to enhance screening yield.
Common questions
What to know about Human Plus Fund
Upseed classifies Human Plus Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.